Pharmacological investigation of genistein for its therapeutic potential against nitroglycerin-induced migraine headache
Journal of Pharmacy and Pharmacology · 06.01.2025 · 77 (1) · 76-94
DOI: 10.1093/jpp/rgae084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 15.07.2024. Verfasst von Qirrat Sajjad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Migraine Disorders, Nitroglycerin, Genistein, Antioxidants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Objectives
Migraine, typically occurs on one side of the head, lasts for hours to days. Trigemino-vascular system (TVS) plays a vital role in pain generation, with neurogenic inflammation and oxidative stress playing key roles in its pathophysiology.
Methods
This study aimed to investigate genistein’s potential as anti-inflammatory and anti-oxidant agent in mitigating migraine pain. Genistein (20 and 50 mg/kg) was administered intraperitoneally (IP) to nitroglycerin (NTG; 10 mg/kg)-induced migraine model in rats. Behavioral analysis, antioxidant assay, immunohistochemistry (IHC), histopathological examination, ELISA, and RT-PCR were conducted to evaluate the antimigraine potential of genistein. key findings In-silico analysis showed genestien’s ACE values of −4.8 to −9.2 Kcal/mol against selected protein targets. Genistein significantly reversed mechanical and thermal nociception, light phobicity, and head scratching; increased the intensities of GST, GSH, catalase; and down regulated lipid peroxidase (LPO) in cortex and trigeminal nucleus caudalis (TNC). It also reduced Nrf2, NF-kB, and IL6 expression, analyzed through IHC, improved histopathological features, and increased COX-2 and decreased PPAR-γ expressions, while RT-PCR analysis revealed increased PPAR-γ expressions in genistein-treated rats.
Conclusion
Genistein exhibited potent antioxidant and anti-inflammatory properties in migraine treatment, acting through multifactorial mechanisms by modulating the expression of numerous proteins in the region cortex and TNC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
ORCID-Profile: Aslam Khan
Zitieren
APA
Sajjad, Q., Khan, A. U., & Khan, A. (2025). Pharmacological investigation of genistein for its therapeutic potential against nitroglycerin-induced migraine headache. Journal of Pharmacy and Pharmacology, 77(1), 76-94. https://doi.org/10.1093/jpp/rgae084
Vancouver
Sajjad Q, Khan AU, Khan A. Pharmacological investigation of genistein for its therapeutic potential against nitroglycerin-induced migraine headache. Journal of Pharmacy and Pharmacology. 2025;77(1):76-94. doi:10.1093/jpp/rgae084
BibTeX
@article{Sajjad2025,
author = {Sajjad, Qirrat and Khan, Arif-Ullah and Khan, Aslam},
title = {Pharmacological investigation of genistein for its therapeutic potential against nitroglycerin-induced migraine headache},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
volume = {77},
number = {1},
pages = {76--94},
doi = {10.1093/jpp/rgae084}
}
EUVIMED